161 related articles for article (PubMed ID: 22941380)
21. Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia.
Pang Y; Holtzman NG
Best Pract Res Clin Haematol; 2023 Jun; 36(2):101475. PubMed ID: 37353287
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapies against human bacterial and fungal infectious diseases: A review.
Qadri H; Shah AH; Alkhanani M; Almilaibary A; Mir MA
Front Med (Lausanne); 2023; 10():1135541. PubMed ID: 37122338
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo expansion of natural killer cells for hematological cancer immunotherapy: a systematic review and meta-analysis.
Çubukçu HC; Mesutoğlu PY; Seval GC; Beksaç M
Clin Exp Med; 2023 Oct; 23(6):2503-2533. PubMed ID: 36333526
[TBL] [Abstract][Full Text] [Related]
24. Natural killer cell infusion for cytomegalovirus infection in pediatric patients with Wiskott-Aldrich syndrome following cord blood transplantation: A case report and literature review.
Yue Y; Meng L; Ling J; Fan L; Zhang Y; Hu Y; Chang AH; Hu S
Front Med (Lausanne); 2022; 9():988847. PubMed ID: 36300184
[TBL] [Abstract][Full Text] [Related]
25. Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Mushtaq MU; Shahzad M; Shah AY; Chaudhary SG; Zafar MU; Anwar I; Neupane K; Khalid A; Ahmed N; Bansal R; Balusu R; Singh AK; Abhyankar SH; Callander NS; Hematti P; McGuirk JP
Front Immunol; 2022; 13():1005031. PubMed ID: 36263054
[TBL] [Abstract][Full Text] [Related]
26. A Phase I Study to Determine the Maximum Tolerated Dose of ex Vivo Expanded Natural Killer Cells Derived from Unrelated, HLA-Disparate Adult Donors.
Otegbeye F; Cooper B; Caimi P; Zamborsky K; Reese-Koc J; Hillian A; Hernandez-Collazo Y; Lee G; Boughan K; Tomlinson B; Gallogly M; Metheny L; Bajor D; Selfridge J; Saltzman J; Lazarus H; de Lima M; Wald D
Transplant Cell Ther; 2022 May; 28(5):250.e1-250.e8. PubMed ID: 35172204
[TBL] [Abstract][Full Text] [Related]
27. The Hematology of Tomorrow Is Here-Preclinical Models Are Not: Cell Therapy for Hematological Malignancies.
Arranz L
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158848
[TBL] [Abstract][Full Text] [Related]
28. Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year.
Heslop HE; Stadtmauer EA; Levine JE; Ballen KK; Chen YB; DeZern AE; Eapen M; Hamadani M; Hamilton BK; Hari P; Jones RJ; Logan BR; Kean LS; Leifer ES; Locke FL; Maziarz RT; Nemecek ER; Pasquini M; Phelan R; Riches ML; Shaw BE; Walters MC; Foley A; Devine SM; Horowitz MM
Transplant Cell Ther; 2021 Nov; 27(11):885-907. PubMed ID: 34461278
[TBL] [Abstract][Full Text] [Related]
29. Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia.
Limongello R; Marra A; Mancusi A; Bonato S; Hoxha E; Ruggeri L; Hui S; Velardi A; Pierini A
Front Immunol; 2021; 12():695051. PubMed ID: 34413848
[TBL] [Abstract][Full Text] [Related]
30. Cytokine-Induced Memory-Like NK Cells with High Reactivity against Acute Leukemia Blasts and Solid Tumor Cells Suitable for Adoptive Immunotherapy Approaches.
Tanzi M; Consonni M; Falco M; Ferulli F; Montini E; Pasi A; Cacciatore R; Brugnatelli S; Pedrazzoli P; Zecca M; Boghen S; Dellabona P; Casorati G; Montagna D
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808051
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future.
Lamb MG; Rangarajan HG; Tullius BP; Lee DA
Stem Cell Res Ther; 2021 Mar; 12(1):211. PubMed ID: 33766099
[TBL] [Abstract][Full Text] [Related]
32. Maintenance Therapy in AML.
Reville PK; Kadia TM
Front Oncol; 2020; 10():619085. PubMed ID: 33604298
[TBL] [Abstract][Full Text] [Related]
33. Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy.
Fernández A; Navarro-Zapata A; Escudero A; Matamala N; Ruz-Caracuel B; Mirones I; Pernas A; Cobo M; Casado G; Lanzarot D; Rodríguez-Antolín C; Vela M; Ferreras C; Mestre C; Viejo A; Leivas A; Martínez J; Fernández L; Pérez-Martínez A
Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33540698
[TBL] [Abstract][Full Text] [Related]
34. Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.
Hamers AAJ; Joshi SK; Pillai AB
OBM Transplant; 2019; 3(1):. PubMed ID: 33511333
[TBL] [Abstract][Full Text] [Related]
35. Natural killer cell-based immunotherapy for acute myeloid leukemia.
Xu J; Niu T
J Hematol Oncol; 2020 Dec; 13(1):167. PubMed ID: 33287858
[TBL] [Abstract][Full Text] [Related]
36. Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer.
Sabry M; Lowdell MW
Stem Cells Transl Med; 2020 Sep; 9(9):974-984. PubMed ID: 32416056
[TBL] [Abstract][Full Text] [Related]
37. High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia.
Müller S; Bexte T; Gebel V; Kalensee F; Stolzenberg E; Hartmann J; Koehl U; Schambach A; Wels WS; Modlich U; Ullrich E
Front Immunol; 2019; 10():3123. PubMed ID: 32117200
[TBL] [Abstract][Full Text] [Related]
38. The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their
Heinze A; Grebe B; Bremm M; Huenecke S; Munir TA; Graafen L; Frueh JT; Merker M; Rettinger E; Soerensen J; Klingebiel T; Bader P; Ullrich E; Cappel C
Front Immunol; 2019; 10():2816. PubMed ID: 31849984
[TBL] [Abstract][Full Text] [Related]
39. NK Cell-Based Immunotherapy for Hematological Malignancies.
Sivori S; Meazza R; Quintarelli C; Carlomagno S; Della Chiesa M; Falco M; Moretta L; Locatelli F; Pende D
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31623224
[TBL] [Abstract][Full Text] [Related]
40. Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors.
Oh S; Lee JH; Kwack K; Choi SW
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
